K-Ras(G12C) inhibitor 9allosteric inhibitor of oncogenic K-Ras(G12C) CAS# 1469337-91-4 |
- NSC 23766
Catalog No.:BCC1149
CAS No.:1177865-17-6
- EHop-016
Catalog No.:BCC5022
CAS No.:1380432-32-5
- K-Ras(G12C) inhibitor 12
Catalog No.:BCC5562
CAS No.:1469337-95-8
- ZCL278
Catalog No.:BCC3665
CAS No.:587841-73-4
- AS 1892802
Catalog No.:BCC6335
CAS No.:928320-12-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1469337-91-4 | SDF | Download SDF |
PubChem ID | 71761630 | Appearance | Powder |
Formula | C16H21ClIN3O4S | M.Wt | 513.78 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in DMSO | ||
Chemical Name | N-[1-[2-(4-chloro-5-iodo-2-methoxyanilino)acetyl]piperidin-4-yl]ethenesulfonamide | ||
SMILES | COC1=CC(=C(C=C1NCC(=O)N2CCC(CC2)NS(=O)(=O)C=C)I)Cl | ||
Standard InChIKey | ZGUSBCDCZNBNQT-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C16H21ClIN3O4S/c1-3-26(23,24)20-11-4-6-21(7-5-11)16(22)10-19-14-9-13(18)12(17)8-15(14)25-2/h3,8-9,11,19-20H,1,4-7,10H2,2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
K-Ras(G12C) inhibitor 9 Dilution Calculator
K-Ras(G12C) inhibitor 9 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.9464 mL | 9.7318 mL | 19.4636 mL | 38.9272 mL | 48.659 mL |
5 mM | 0.3893 mL | 1.9464 mL | 3.8927 mL | 7.7854 mL | 9.7318 mL |
10 mM | 0.1946 mL | 0.9732 mL | 1.9464 mL | 3.8927 mL | 4.8659 mL |
50 mM | 0.0389 mL | 0.1946 mL | 0.3893 mL | 0.7785 mL | 0.9732 mL |
100 mM | 0.0195 mL | 0.0973 mL | 0.1946 mL | 0.3893 mL | 0.4866 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Target: K-Ras(G12C)
IC50: N/A
K-Ras(G12C) inhibitor 9 is an allosteric inhibitor of oncogenic K-Ras(G12C) [1]. Ras proteins belong to the large family of GTPase enzymes which are essential to transduce extracellular signals into diverse cellular responses including proliferation, differentiation, and apoptosis. About 30% of all human cancers contain activating Ras mutations, making them one of the most common known genetic molecular drivers of cancer [2]. Therefore, K-Ras signaling have potential therapeutic advantages in cancer. K-Ras(G12C) is present in roughly 10–20% of Ras-driven cancers and in an estimated 50% of Ras-mutated lung adenocarcinomas [3].
In vitro: K-Ras(G12C) inhibitor 9 belongs to a series of small molecules, which irreversibly compete with GTP and GDP for binding to a common oncogenic K-Ras(G12C) mutant and blocked the association of B-Raf and C-Raf with K-Ras(G12C). K-Ras(G12C) inhibitor 9 (10 μM) decreased viability and increased apoptosis of G12C mutations-containing lung cancer cell lines (H1792, Calu-1, H358, and H23) [1].
In vivo: N/A
References:
1. Ostrem JM, Peters U, Sos ML, Wells JA, Shokat KM. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature. 2013;503(7477):548-51.
2. Hunter JC, Gurbani D, Ficarro SB, Carrasco MA, Lim SM, Choi HG, et al. In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C. Proc Natl Acad Sci U S A. 2014;111(24):8895-900.
3. Lim SM, Westover KD, Ficarro SB, Harrison RA, Choi HG, Pacold ME, et al. Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitor. Angew Chem Int Ed Engl. 2014;53(1):199-204.
- 1,2-Diacetoxy-4,7,8-trihydroxy-3-(4-hydroxyphenyl)dibenzofuran
Catalog No.:BCN7691
CAS No.:146905-24-0
- Triptobenzene H
Catalog No.:BCN6784
CAS No.:146900-55-2
- 1,5-Dihydroxyxanthone
Catalog No.:BCN7423
CAS No.:14686-65-8
- 2-Bromo-1-(3-thienyl)-1-ethanone
Catalog No.:BCN2657
CAS No.:1468-82-2
- Y-29794 oxalate
Catalog No.:BCC5795
CAS No.:146794-84-5
- N-desmethyldauricine
Catalog No.:BCC8217
CAS No.:146763-55-5
- Boc-D-Phe(4-CN)-OH
Catalog No.:BCC3183
CAS No.:146727-62-0
- ZD 7155 hydrochloride
Catalog No.:BCC5734
CAS No.:146709-78-6
- Daphnicyclidin I
Catalog No.:BCN7038
CAS No.:1467083-10-8
- Hybridaphniphylline B
Catalog No.:BCN7045
CAS No.:1467083-09-5
- Hybridaphniphylline A
Catalog No.:BCN7042
CAS No.:1467083-07-3
- SR 11237
Catalog No.:BCC7681
CAS No.:146670-40-8
- K-Ras(G12C) inhibitor 12
Catalog No.:BCC5562
CAS No.:1469337-95-8
- Ziprasidone
Catalog No.:BCC2071
CAS No.:146939-27-7
- Codaphniphylline
Catalog No.:BCN1652
CAS No.:14694-15-6
- Fmoc-Asp(OAll)-OH
Catalog No.:BCC3089
CAS No.:146982-24-3
- Fmoc-Lys(Aloc)-OH
Catalog No.:BCC3515
CAS No.:146982-27-6
- Y-27632
Catalog No.:BCC4301
CAS No.:146986-50-7
- Y-27632 dihydrochloride
Catalog No.:BCC1273
CAS No.:129830-38-2
- Atglistatin
Catalog No.:BCC5104
CAS No.:1469924-27-3
- QL47
Catalog No.:BCC3920
CAS No.:1469988-75-7
- Diphenhydramine hydrochloride
Catalog No.:BCC8947
CAS No.:147-24-0
- DL-Arabinose
Catalog No.:BCN8541
CAS No.:147-81-9
- Proline
Catalog No.:BCN1656
CAS No.:147-85-3